QSI / Quantum-Si: Market Overreaction May Provide An Excellent Entry Point

Quantum-Si incorporated is a pioneering company in the field of proteomics with its innovative Platinum platform. The company's revenue model is still more_horizontal

Quantum-SI released its Q2 2023 earnings report, which showed lower-than-expected revenue and reduced forward guidance. The company shelved its carbon more_horizontal

Quantum-Si stock beat on earnings this morning, but suffered a sales miss. Worse than that, sales actually slowed down between Q1 and Q2. more_horizontal

Quantum-Si incorporated (NASDAQ:QSI ) Q2 2023 Earnings Conference Call August 7, 2023 8:30 AM ET Company Participants Juan Avendano - Head, Investor R more_horizontal

The medical-equipment maker specializes in equipment for the large-scale studying of proteins. The company went public in 2021. more_horizontal

Quantum-Si stock jumped early in Friday's trading on news that Ark Invest had purchased more shares. But investors taking profit on the stock and a re more_horizontal

Cathie Wood's Ark Genomic Revolution ETF has added to its Quantum-Si position. The company said it plans to launch a second protein sequencing product more_horizontal

Quantum-Si's proprietary protein detection platform has begun generating revenue, although it's not expected to significantly affect the cash-burn rat more_horizontal